Approximately 90 percent of people on therapeutic doses lose at least 5 percent of their body weight, which is considered clinically significant
Notably, GLP-1 analogs that can pass the BBB have been shown to produce strong neuroprotective effects in preclinical models of Alzheimers disease, Parkinsons disease, stroke, and other neurological conditions
Growing National Reach Footprint With a diverse portfolio of over 60 products Most orders ship within 48 Hours At Wells Pharma of Houston , we proudly support hospitals nationwide with ready-to-use sterile solutions that ensure patient safety, even in times of shortage
For instance, hospitalized patients with severe alcohol-related malnutrition might receive 1 mL IM daily for a week
Allergic reactions (rash, trouble breathing) are rare but possible (Healthline)